drugset / Trial / NCT00655356
Safety and Efficacy Study of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety profile and the treatment effect of Isolagen TherapyTM compared with placebo when administered to bilateral nasolabial fold wrinkles.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-07
- Completion
- 2009-05
Outcome
Met primary endpoint
registry NUMBER Autologous Fibroblasts: 50 participants NUMBER Placebo: 19 participants analysis (superiority or other test); Autologous Fibroblasts vs Placebo; p <.00001 NCT00655356 ↗
registry NUMBER Autologous Fibroblasts: 21 participants NUMBER Placebo: 8 participants analysis (superiority or other test); Autologous Fibroblasts vs Placebo; p = .0075 NCT00655356 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | azficel-T | Cell therapy | — | Other |
Indications
No indication recorded.